110845 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus B, i.e. influenza B virus; Methods of inactivation or attenuation by genetic engineering
INFLUENZA VIRUS MUTANTS AND USES THEREFOR
#2Influenza virus mutants and uses therefor
#3Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#4Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#5Influenza virus mutants and uses therefor
#6Influenza virus mutants and uses therefor
#7Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#8Recombinant Influenza Virus
#9ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#10Influenza virus mutants and uses therefor
#11Influenza virus mutants and uses therefor
#12Multi plasmid system for the production of influenza virus
#13Influenza virus mutants and uses therefor
#14Multi plasmid system for the production of influenza virus
#15Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#16Influenza viruses and uses thereof
#17Multi plasmid system for the production of influenza virus
#18Influenza hemagglutinin and neuraminidase variants
#19NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#20ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#21Neuraminidase-deficient live influenza vaccines
#22Methods for the propagation of modified influenza viruses in embryonated eggs
#23Method for producing temperature sensitive influenza A viruses
#24Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#25Multi plasmid system for the production of influenza virus
#26Methods and interferon deficient substrates for the propagation of viruses